Abstract
INTRODUCTION: Poliomyelitis is a disease caused by poliovirus that can cause life-long paralysis and death. Malaysia was declared polio-free in 2000, following no polio case was detected since 1992. Unfortunately, in December 2019 one polio case was detected in Kota Kinabalu, Sabah. As an immediate response to the outbreak, Kempen Imunisasi Polio Sabah (KIPS) was initiated throughout the state. The campaign's main objective was to ensure immunisation coverage for polio was more than 95%. METHODOLOGY: Kempen Imunisasi Polio Sabah (KIPS) is a Supplementary Immunisation Activity (SIA) that commenced simultaneously throughout Sabah from December 2019 for a period of one year. In Tawau, the SIA was tasked to the Emergency Operating Centre for Polio (EOC Polio), led by Tawau Health Officer. The target group was all children under the age of 13 years old. Polio vaccine was administered in the form of bivalent Oral Polio Vaccine type 1 and 3 (bOPV) and monovalent Oral Polio Vaccine type 2 (mOPV2). The SIA was executed using fixed post and door-to-door methods. Both methods are done at various health facilities, government and private schools, and community outreach at villages, town halls and plantations. In addition, these communities were exposed to a series of polio awareness and education campaigns. RESULTS: A total number of 79,872 children under 13 years old were eligible for bOPV and mOPV2 vaccination in the Tawau. By the end of the campaign on 15th December 2020, OPV coverage was more than 95%. A total of 80, 250 (100%) children received bOPV dose 1, 80,189 (100%) children received bOPV dose 2, 79,444 (99%) children received mOPV dose 1 and 77,763(97%) children received mOPV dose 2. DISCUSSION: After twelve months of the campaign, the polio immunisation coverage was more than 95%, achieving the target the Ministry of Health set. In addition, throughout the campaign period, no polio case was detected in Tawau. Despite all limitations during the COVID-19 pandaemic, the EOC Polio team executed the strategic planning well. Great teamwork and established networking with other agencies, either government or non-government bodies, proved to be the key to the polio campaign's success in Tawau.
Links
- https://apcph.cphm.my/wp-content/uploads/2022/07/APCPH2022-P-82.pdf
- https://apcph.cphm.my/wp-content/uploads/wpforms/1176-1e04940bb5d885bf8711ed1909[...]
BibTeX (Download)
@proceedings{APCPH2022-P-82,
title = {Polio Supplementary Immunisation Activity During Covid-19 Pandaemic In Tawau, Sabah},
author = {Nur Sulastini Md Nor and Suzalinna Sulaiman and G. Navindran},
url = {https://apcph.cphm.my/wp-content/uploads/2022/07/APCPH2022-P-82.pdf
https://apcph.cphm.my/wp-content/uploads/wpforms/1176-1e04940bb5d885bf8711ed19095a89ed/APCPH2022-P-82-bcd05688f5002a23b980c0b39cd0ed4d.pdf},
year = {2022},
date = {2022-08-02},
urldate = {2022-08-02},
issue = {7},
abstract = {INTRODUCTION: Poliomyelitis is a disease caused by poliovirus that can cause life-long paralysis and death. Malaysia was declared polio-free in 2000, following no polio case was detected since 1992. Unfortunately, in December 2019 one polio case was detected in Kota Kinabalu, Sabah. As an immediate response to the outbreak, Kempen Imunisasi Polio Sabah (KIPS) was initiated throughout the state. The campaign's main objective was to ensure immunisation coverage for polio was more than 95%. METHODOLOGY: Kempen Imunisasi Polio Sabah (KIPS) is a Supplementary Immunisation Activity (SIA) that commenced simultaneously throughout Sabah from December 2019 for a period of one year. In Tawau, the SIA was tasked to the Emergency Operating Centre for Polio (EOC Polio), led by Tawau Health Officer. The target group was all children under the age of 13 years old. Polio vaccine was administered in the form of bivalent Oral Polio Vaccine type 1 and 3 (bOPV) and monovalent Oral Polio Vaccine type 2 (mOPV2). The SIA was executed using fixed post and door-to-door methods. Both methods are done at various health facilities, government and private schools, and community outreach at villages, town halls and plantations. In addition, these communities were exposed to a series of polio awareness and education campaigns. RESULTS: A total number of 79,872 children under 13 years old were eligible for bOPV and mOPV2 vaccination in the Tawau. By the end of the campaign on 15th December 2020, OPV coverage was more than 95%. A total of 80, 250 (100%) children received bOPV dose 1, 80,189 (100%) children received bOPV dose 2, 79,444 (99%) children received mOPV dose 1 and 77,763(97%) children received mOPV dose 2. DISCUSSION: After twelve months of the campaign, the polio immunisation coverage was more than 95%, achieving the target the Ministry of Health set. In addition, throughout the campaign period, no polio case was detected in Tawau. Despite all limitations during the COVID-19 pandaemic, the EOC Polio team executed the strategic planning well. Great teamwork and established networking with other agencies, either government or non-government bodies, proved to be the key to the polio campaign's success in Tawau.},
howpublished = {published online at https://apcph.cphm.my},
note = {Type: POSTER PRESENTATION; Organisation: Tawau Health Office, Sabah, Bintulu Hospital, Sarawak},
keywords = {OPV coverage, Polio, Sabah, Supplementary Immunisation Activity},
pubstate = {published},
tppubtype = {proceedings}
}